{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:07:49Z","timestamp":1763510869739,"version":"3.45.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"DOI":"10.1186\/s13098-025-02009-8","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T11:22:44Z","timestamp":1763464964000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Molecular impact of single nucleotide polymorphisms in GIPR gene among type 2 diabetes mellitus patients in the Saudi population"],"prefix":"10.1186","volume":"17","author":[{"given":"Zeina S.","family":"Alkudmani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yazeed","family":"Alshuweishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah F.","family":"Alsobaie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9746-5300","authenticated-orcid":false,"given":"Imran","family":"Ali Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"key":"2009_CR1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.4093\/dmj.2024.0818","volume":"49","author":"SE Park","year":"2025","unstructured":"Park SE, Ko S-H, Kim JY, Kim K, Moon JH, Kim NH, et al. Diabetes fact sheets in Korea 2024. Diabetes Metabolism J. 2025;49:24\u201333.","journal-title":"Diabetes Metabolism J"},{"key":"2009_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-025-01894-4","volume":"25","author":"SA Alshaikhi","year":"2025","unstructured":"Alshaikhi SA, Alfaqih FH, Alrashdi AK, Alamri FA, Alzubaidi AS, Alnashri AI, et al. Assessment of self-efficacy, quality of life, and well-being of patients with diabetes mellitus in Alqunfudah, Saudi Arabia. BMC Endocr Disord. 2025;25:91.","journal-title":"BMC Endocr Disord"},{"key":"2009_CR3","unstructured":"Alghamdi RAA, Almalky FY, Thigah AA, Alosaimi GHH, Alsuwat SAT. Diabetes Outcomes in Saudi Arabia: A Nationwide Assessment of Glycemic Control and Complications in Primary Health Centers. MIDDLE EAST JOURNAL OF FAMILY MEDICINE.7."},{"issue":"6","key":"2009_CR4","doi-asserted-by":"publisher","first-page":"617","DOI":"10.15537\/smj.2025.46.6.202501212","volume":"46","author":"MA Jeraiby","year":"2025","unstructured":"Jeraiby MA, Moshi JM, Maashi SM, Shubaili AI, Nadeem MS, Abdelwahab SI, et al. Trends in diabetes mellitus prevalence and gender disparities in Jazan, Saudi Arabia: a retrospective analysis. Saudi Med J. 2025;46(6):617.","journal-title":"Saudi Med J"},{"key":"2009_CR5","doi-asserted-by":"publisher","first-page":"481","DOI":"10.15537\/smj.2021.42.5.20200676","volume":"42","author":"MZ Aljulifi","year":"2021","unstructured":"Aljulifi MZ. Prevalence and reasons of increased type 2 diabetes in Gulf Cooperation Council countries. Saudi Med J. 2021;42:481.","journal-title":"Saudi Med J"},{"key":"2009_CR6","unstructured":"Saleh S. Prevalence of diabetes in Saudi Arabia from 2016 to 2020 with forecasts for 2021 and 2026. Health, Pharma & Medtech; 2024."},{"key":"2009_CR7","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1056\/NEJMoa2313917","volume":"390","author":"MN Kosiborod","year":"2024","unstructured":"Kosiborod MN, Petrie MC, Borlaug BA, Butler J, Davies MJ, Hovingh GK, et al. Semaglutide in patients with obesity-related heart failure and type 2 diabetes. N Engl J Med. 2024;390:1394\u2013407.","journal-title":"N Engl J Med"},{"key":"2009_CR8","doi-asserted-by":"publisher","unstructured":"Accili, D., Deng, Z. & Liu, Q. Insulin resistance in type 2 diabetes mellitus. Nat Rev Endocrinol 21, 413\u2013426 (2025). https:\/\/doi.org\/10.1038\/s41574-025-01114-y.","DOI":"10.1038\/s41574-025-01114-y"},{"key":"2009_CR9","doi-asserted-by":"crossref","unstructured":"Demircan K, Chillon TS, Bang J, Gladyshev VN, Schomburg L. Selenium, diabetes, and their intricate sex-specific relationship. Trends in Endocrinology & Metabolism; 2024.","DOI":"10.1016\/j.tem.2024.03.004"},{"key":"2009_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2024.116212","volume":"274","author":"T Guo","year":"2024","unstructured":"Guo T, Cheng X, Wei J, Chen S, Zhang Y, Lin S, et al. Unveiling causal connections: Long-term particulate matter exposure and type 2 diabetes mellitus mortality in Southern China. Ecotoxicol Environ Saf. 2024;274:116212.","journal-title":"Ecotoxicol Environ Saf"},{"key":"2009_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3778","volume":"40","author":"L Verde","year":"2024","unstructured":"Verde L, Di Lorenzo T, Savastano S, Colao A, Barrea L, Muscogiuri G. Chrononutrition in type 2 diabetes mellitus and obesity: a narrative review. Diabetes Metab Res Rev. 2024;40:e3778.","journal-title":"Diabetes Metab Res Rev"},{"key":"2009_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.obmed.2025.100611","author":"RL Triandhini","year":"2025","unstructured":"Triandhini RL, Sadewa AH, Helmiyati S. Exploring genes related to impaired insulin secretion and the interaction with diet in type 2 diabetes mellitus: a scoping review of observational studies. Obes Med. 2025. https:\/\/doi.org\/10.1016\/j.obmed.2025.100611","journal-title":"Obes Med"},{"key":"2009_CR13","doi-asserted-by":"crossref","unstructured":"Lewandowski SL, El K, Campbell JE. Evaluating glucose-dependent insulinotropic polypeptide and glucagon as key regulators of insulin secretion in the pancreatic islet. American Journal of Physiology-Endocrinology and Metabolism. 2024;327(1):E103\u2013E10","DOI":"10.1152\/ajpendo.00360.2023"},{"key":"2009_CR14","doi-asserted-by":"publisher","first-page":"3145","DOI":"10.1194\/jlr.M006841","volume":"51","author":"S-J Kim","year":"2010","unstructured":"Kim S-J, Nian C, McIntosh CH. GIP increases human adipocyte LPL expression through CREB and TORC2-mediated trans-activation of the LPL gene. J Lipid Res. 2010;51:3145\u201357.","journal-title":"J Lipid Res"},{"key":"2009_CR15","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1530\/EJE-10-0444","volume":"163","author":"J Sauber","year":"2010","unstructured":"Sauber J, Grothe J, Behm M, Scherag A, Grallert H, Illig T, et al. Association of variants in gastric inhibitory polypeptide receptor gene with impaired glucose homeostasis in obese children and adolescents from Berlin. Eur J Endocrinol. 2010;163:259\u201364.","journal-title":"Eur J Endocrinol"},{"key":"2009_CR16","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/ng.521","volume":"42","author":"R Saxena","year":"2010","unstructured":"Saxena R, Hivert M-F, Langenberg C, Tanaka T, Pankow JS, Vollenweider P, et al. Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet. 2010;42:142\u20138.","journal-title":"Nat Genet"},{"key":"2009_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-023-01477-z","volume":"16","author":"S Erfanian","year":"2023","unstructured":"Erfanian S, Mir H, Abdoli A, Roustazadeh A. Association of gastric inhibitory polypeptide receptor (GIPR) gene polymorphism with type 2 diabetes mellitus in Iranian patients. BMC Med Genomics. 2023;16:44.","journal-title":"BMC Med Genomics"},{"key":"2009_CR18","doi-asserted-by":"publisher","first-page":"E908","DOI":"10.1210\/jc.2013-3350","volume":"99","author":"V Ceperuelo-Mallafr\u00e9","year":"2014","unstructured":"Ceperuelo-Mallafr\u00e9 V, Duran X, Pach\u00f3n G, Roche K, Garrido-S\u00e1nchez L, Vilarrasa N, et al. Disruption of GIP\/GIPR axis in human adipose tissue is linked to obesity and insulin resistance. J Clin Endocrinol Metabolism. 2014;99:E908\u201319.","journal-title":"J Clin Endocrinol Metabolism"},{"key":"2009_CR19","doi-asserted-by":"publisher","first-page":"E61","DOI":"10.1152\/ajpendo.00358.2007","volume":"294","author":"N Harada","year":"2008","unstructured":"Harada N, Yamada Y, Tsukiyama K, Yamada C, Nakamura Y, Mukai E, et al. A novel GIP receptor splice variant influences GIP sensitivity of pancreatic \u03b2-cells in obese mice. Am J Physiology-Endocrinology Metabolism. 2008;294:E61\u20138.","journal-title":"Am J Physiology-Endocrinology Metabolism"},{"key":"2009_CR20","doi-asserted-by":"publisher","first-page":"292","DOI":"10.2337\/db23-0172","volume":"73","author":"EC Furber","year":"2024","unstructured":"Furber EC, Hyatt K, Collins K, Yu X, Droz BA, Holland A, et al. GIPR agonism enhances TZD-induced insulin sensitivity in obese IR mice. Diabetes. 2024;73:292\u2013305.","journal-title":"Diabetes"},{"key":"2009_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2023.101831","volume":"78","author":"L Yammine","year":"2023","unstructured":"Yammine L, Picatoste B, Abdullah N, Leahey RA, Johnson EF, G\u00f3mez-Banoy N, et al. Spatiotemporal regulation of GIPR signaling impacts glucose homeostasis as revealed in studies of a common GIPR variant. Mol Metab. 2023;78:101831.","journal-title":"Mol Metab"},{"key":"2009_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.2973","volume":"19","author":"SM Shalaby","year":"2017","unstructured":"Shalaby SM, Zidan HE, Shokry A, Saeed J, El-Sokkary RH. Association of incretin receptors genetic polymorphisms with type 2 diabetes mellitus in Egyptian patients. J Gene Med. 2017;19:e2973.","journal-title":"J Gene Med"},{"key":"2009_CR23","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.2337\/diabetes.50.11.2497","volume":"50","author":"JJ Meier","year":"2001","unstructured":"Meier JJ, Hucking K, Holst JJ, Deacon CF, Schmiegel WH, Nauck MA. Reduced insulinotropic effect of gastric inhibitory polypeptide in first-degree relatives of patients with type 2 diabetes. Diabetes. 2001;50:2497\u2013504.","journal-title":"Diabetes"},{"key":"2009_CR24","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1007\/s00125-002-0878-6","volume":"45","author":"T Vilsb\u00f8ll","year":"2002","unstructured":"Vilsb\u00f8ll T, Krarup T, Madsbad S, Holst J. Defective amplification of the late phase insulin response to glucose by GIP in obese type II diabetic patients. Diabetologia. 2002;45:1111\u20139.","journal-title":"Diabetologia"},{"key":"2009_CR25","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1530\/EJE-13-0487","volume":"169","author":"M Alssema","year":"2013","unstructured":"Alssema M, Rijkelijkhuizen JM, Holst JJ, Teerlink T, Scheffer PG, Eekhoff EM, et al. Preserved GLP-1 and exaggerated GIP secretion in type 2 diabetes and relationships with triglycerides and ALT. Eur J Endocrinol. 2013;169:421\u201330.","journal-title":"Eur J Endocrinol"},{"key":"2009_CR26","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1134\/S1990750818030071","volume":"12","author":"D Skuratovskaia","year":"2018","unstructured":"Skuratovskaia D, Vulf M, Kirienkova E, Mironyuk N, Zatolokin P, Litvinova L. The role of single nucleotide polymorphisms in the GIPR gene in regulation of secretion of hormones and adipokines in obese patients with type 2 diabetes mellitus. Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry. 2018;12:266\u201374.","journal-title":"Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry"},{"key":"2009_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2019.170237","volume":"125","author":"RL Barbosa-Ya\u00f1ez","year":"2020","unstructured":"Barbosa-Ya\u00f1ez RL, Markova M, Dambeck U, Honsek C, Machann J, Sch\u00fcler R, et al. Predictive effect of GIPR SNP rs10423928 on glucose metabolism liver fat and adiposity in prediabetic and diabetic subjects. Peptides. 2020;125:170237.","journal-title":"Peptides"},{"key":"2009_CR28","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1111\/dom.13634","volume":"21","author":"SF Jacobi","year":"2019","unstructured":"Jacobi SF, Khajavi N, Kleinau G, Teumer A, Scheerer P, Homuth G, et al. Evaluation of a rare glucose-dependent insulinotropic polypeptide receptor variant in a patient with diabetes. Diabetes Obes Metab. 2019;21:1168\u201376.","journal-title":"Diabetes Obes Metab"},{"key":"2009_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.endmts.2023.100140","volume":"13","author":"SM Nameghi","year":"2023","unstructured":"Nameghi SM. Association of GIPR gene variant on the risk of type 2 diabetes mellitus: a case-control study. Endocrine and Metabolic Science. 2023;13:100140.","journal-title":"Endocrine and Metabolic Science"},{"key":"2009_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2350-10-19","volume":"10","author":"CI Vogel","year":"2009","unstructured":"Vogel CI, Scherag A, Br\u00f6nner G, Nguyen TT, Wang H-J, Grallert H, et al. Gastric inhibitory polypeptide receptor: association analyses for obesity of several polymorphisms in large study groups. BMC Med Genet. 2009;10:1\u201310.","journal-title":"BMC Med Genet"},{"key":"2009_CR31","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1002\/mnfr.200700048","volume":"51","author":"I Nitz","year":"2007","unstructured":"Nitz I, Fisher E, Weikert C, Burwinkel B, Li Y, M\u00f6hlig M, et al. Association analyses of GIP and GIPR polymorphisms with traits of the metabolic syndrome. Mol Nutr Food Res. 2007;51:1046\u201352.","journal-title":"Mol Nutr Food Res"},{"key":"2009_CR32","unstructured":"Skuratovskaia D, Fattakhov N, Vasilenko M, Kirienkova E, Zatolokin P, Mironyuk N et al. Association of GIPR rs2302382 polymorphism with type 2 diabetes in Russian subjects with abdominal obesity."},{"key":"2009_CR33","volume-title":"Statistics for windows, version 25.0. Armonk","author":"S IBMCorp Ibm","year":"2017","unstructured":"IBMCorp Ibm S. Statistics for windows, version 25.0. Armonk. NY: IBM Corp; 2017."},{"key":"2009_CR34","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1093\/bioinformatics\/btl268","volume":"22","author":"X Sol\u00e9","year":"2006","unstructured":"Sol\u00e9 X, Guin\u00f3 E, Valls J, Iniesta R, Moreno V. Snpstats: a web tool for the analysis of association studies. Bioinformatics. 2006;22:1928\u20139.","journal-title":"Bioinformatics"},{"key":"2009_CR35","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1093\/bioinformatics\/bth457","volume":"21","author":"JC Barrett","year":"2005","unstructured":"Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263\u20135.","journal-title":"Bioinformatics"},{"key":"2009_CR36","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1086\/518312","volume":"80","author":"X-Y Lou","year":"2007","unstructured":"Lou X-Y, Chen G-B, Yan L, Ma JZ, Zhu J, Elston RC, et al. A generalized combinatorial approach for detecting gene-by-gene and gene-by-environment interactions with application to nicotine dependence. Am J Hum Genet. 2007;80:1125\u201337.","journal-title":"Am J Hum Genet"},{"key":"2009_CR37","first-page":"39","volume":"31","author":"H Motulsky","year":"2007","unstructured":"Motulsky H. Prism 5 statistics guide, 2007. GraphPad Softw. 2007;31:39\u201342.","journal-title":"GraphPad Softw"},{"key":"2009_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s40246-022-00383-2","volume":"16","author":"I Akhlaghipour","year":"2022","unstructured":"Akhlaghipour I, Bina AR, Mogharrabi MR, Fanoodi A, Ebrahimian AR, Khojasteh Kaffash S, et al. Single-nucleotide polymorphisms as important risk factors of diabetes among middle East population. Hum Genomics. 2022;16:11.","journal-title":"Hum Genomics"},{"key":"2009_CR39","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v12.i9.1401","volume":"12","author":"IM El-Kebbi","year":"2021","unstructured":"El-Kebbi IM, Bidikian NH, Hneiny L, Nasrallah MP. Epidemiology of type 2 diabetes in the Middle East and North Africa: challenges and call for action. World J Diabetes. 2021;12:1401.","journal-title":"World J Diabetes"},{"key":"2009_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1278103","volume":"11","author":"BG Abd El-Razik Siam","year":"2023","unstructured":"Abd El-Razik Siam BG, Abdou Rizk SM, Mahmoud SKM. The risk of developing type 2 diabetes mellitus among the students of Hail University, Saudi Arabia. Front Public Health. 2023;11:1278103.","journal-title":"Front Public Health"},{"key":"2009_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2023.170939","volume":"161","author":"CJ Bailey","year":"2023","unstructured":"Bailey CJ, Flatt PR, Conlon JM. An update on peptide-based therapies for type 2 diabetes and obesity. Peptides. 2023;161:170939.","journal-title":"Peptides"},{"key":"2009_CR42","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41574-020-00459-w","volume":"17","author":"J Ghislain","year":"2021","unstructured":"Ghislain J, Poitout V. Targeting lipid GPCRs to treat type 2 diabetes mellitus\u2014progress and challenges. Nat Rev Endocrinol. 2021;17:162\u201375.","journal-title":"Nat Rev Endocrinol"},{"key":"2009_CR43","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1007\/s001250051051","volume":"41","author":"K Almind","year":"1998","unstructured":"Almind K, Ambye L, Urhammer S, Hansen T, Echwald S, Holst J, et al. Discovery of amino acid variants in the human glucose-dependent insulinotropic polypeptide (GIP) receptor: the impact on the pancreatic beta cell responses and functional expression studies in Chinese hamster fibroblast cells. Diabetologia. 1998;41:1194\u20138.","journal-title":"Diabetologia"},{"key":"2009_CR44","doi-asserted-by":"publisher","first-page":"726","DOI":"10.2337\/db10-1331","volume":"60","author":"CL Chang","year":"2011","unstructured":"Chang CL, Cai JJ, Cheng PJ, Chueh HY, Hsu SYT. Identification of metabolic modifiers that underlie phenotypic variations in energy-balance regulation. Diabetes. 2011;60:726\u201334.","journal-title":"Diabetes"},{"key":"2009_CR45","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s100380200056","volume":"47","author":"T Okuda","year":"2002","unstructured":"Okuda T, Fujioka Y, Kamide K, Kawano Y, Goto Y, Yoshimasa Y, et al. Verification of 525 coding SNPs in 179 hypertension candidate genes in the Japanese population: identification of 159 SNPs in 93 genes. J Hum Genet. 2002;47:387\u201394.","journal-title":"J Hum Genet"},{"key":"2009_CR46","doi-asserted-by":"crossref","unstructured":"Mattos AMS, Costa SC, Outuki G, Koga GKC, Montemor CN, Longo GZ et al. Association of the GIPR Glu354Gln (rs1800437) polymorphism with hypertension in a Brazilian population. BioRxiv. 2018:340539.","DOI":"10.1101\/340539"},{"key":"2009_CR47","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.2337\/db21-0103","volume":"70","author":"N Bowker","year":"2021","unstructured":"Bowker N, Hansford R, Burgess S, Foley CN, Auyeung VP, Erzurumluoglu AM, et al. Genetically predicted glucose-dependent insulinotropic polypeptide (GIP) levels and cardiovascular disease risk are driven by distinct causal variants in the GIPR region. Diabetes. 2021;70:2706\u201319.","journal-title":"Diabetes"},{"key":"2009_CR48","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1176\/appi.neuropsych.13120389","volume":"27","author":"S Ono","year":"2015","unstructured":"Ono S, Suzuki Y, Fukui N, Sawamura K, Sugai T, Watanabe J, et al. GIPR gene polymorphism and weight gain in patients with schizophrenia treated with olanzapine. J Neuropsychiatry Clin Neurosci. 2015;27:162\u20134.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"2009_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/genes13091534","volume":"13","author":"J Micha\u0142owska","year":"2022","unstructured":"Micha\u0142owska J, Miller-Kasprzak E, Seraszek-Jaros A, Mostowska A, Bogda\u0144ski P. The link between three single nucleotide variants of the GIPR gene and metabolic health. Genes. 2022;13:1534.","journal-title":"Genes"},{"key":"2009_CR50","doi-asserted-by":"crossref","unstructured":"Zhang L, He J, Sun X, Pang D, Hu J, Feng B. Relationship between GIP receptor gene polymorphism rs10423928 and bone mineral density in postmenopausal women in Shanghai. 2020.","DOI":"10.21203\/rs.3.rs-123626\/v1"},{"key":"2009_CR51","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1111\/dom.12682","volume":"18","author":"M Javorsk\u00fd","year":"2016","unstructured":"Javorsk\u00fd M, Gotthardov\u00e1 I, Klim\u010d\u00e1kov\u00e1 L, Kvapil M, \u017didzik J, Schroner Z, et al. A missense variant in GLP1R gene is associated with the glycaemic response to treatment with gliptins. Diabetes Obes Metab. 2016;18:941\u20134.","journal-title":"Diabetes Obes Metab"},{"key":"2009_CR52","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.2337\/db10-1532","volume":"60","author":"V Lyssenko","year":"2011","unstructured":"Lyssenko V, Eliasson L, Kotova O, Pilgaard K, Wierup N, Salehi A, et al. Pleiotropic effects of GIP on islet function involve osteopontin. Diabetes. 2011;60:2424\u201333.","journal-title":"Diabetes"},{"key":"2009_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-020-00819-1","volume":"13","author":"Y Bylstra","year":"2021","unstructured":"Bylstra Y, Lim WK, Kam S, Tham KW, Wu RR, Teo JX, et al. Family history assessment significantly enhances delivery of precision medicine in the genomics era. Genome Med. 2021;13:3.","journal-title":"Genome Med"}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-025-02009-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-025-02009-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-025-02009-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:05:17Z","timestamp":1763510717000},"score":1,"resource":{"primary":{"URL":"https:\/\/dmsjournal.biomedcentral.com\/articles\/10.1186\/s13098-025-02009-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2009"],"URL":"https:\/\/doi.org\/10.1186\/s13098-025-02009-8","relation":{},"ISSN":["1758-5996"],"issn-type":[{"type":"electronic","value":"1758-5996"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"28 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained for this study from King Saud University (E-23-7835). Informed consent forms were obtained from each of the individuals who has participated in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"435"}}